Health effects of smoking tobacco, smokeless tobacco and nicotine:

 

Female infertility1

Summary:

·        Cigarette smoking. There is strong epidemiological and biochemical evidence that cigarette smoking damages female fertility.

·        Smokeless tobacco: The evidence for smokeless tobacco affecting female fertility is virtually lacking. Smokeless tobacco and NRT contain nicotine, which make constrict the blood supply to the oviduct, but no epidemiological studies have been carried out.

Anatomy of the oviduct (Fallopian tube) The oviduct (consisting of infundibulum which wraps around ovary, the ampulla where the tube opens close to the ovary, and the isthmus the narrow tube leading to the uterus),

Pathology. The oviduct, if malfunctioning, is likely to be associated with increased infertility and ectopic pregnancy.

Epidemiological evidence. Women of child bearing age who actively inhale mainstream smoke have higher rates of infertility, spontaneous abortion, ectopic pregnancy, tubal infertility, increased time to conception, and intrauterine growth retardation, than nonsmokers.

Physiological evidence. The oviduct’s infundibulum picks up the oocyte complex and moves it to the ampulla where fertilization occurs. Simultaneously the oviduct moves sperm from uterus to ampulla, later moves the fertilized embryo back along the oviduct to the uterus, timing this move in response to hormonal or chemical signals from the woman and the embryo, to provide the best receptivity for implantation.

 

Most current evidence links smoke to effects on:

  • The oocyte pickup process. This process has been observed during laparoscopic surgery. It depends on (i) ciliary beating of cells and (ii) their stickiness on the surface epithelium of both oocyte and oviduct infundibular fimbria.
  • Embryo transport. This depends on (i) Ciliary beating. The ampulla and isthmus sections of the oviduct are lined by ciliary cells which beat towards the uterus. (ii) Smooth muscle contraction.

 

Effect of smoking tobacco, smokeless tobacco, and nicotine

Cigarette smoke

Smokeless tobacco

Nicotine products

Ciliary beat frequency

Mainstream smoke solutions of cigarette brands, filtered or unfiltered, inhibit the frequency of the beat of cilia in the oviduct in a dose dependent manner.

Cyanide (as HCN) is present in cigarette smoke (typically 300 micrograms per Holiday cigarette, 480 micrograms per Marlboro cigarette) and in cigarette smoke solutions as KCN, in sufficient quantity to inhibit the oocyte pickup rate and  in-vitro infundibular bio-assay. The effect is dose-dependent.

Contains nicotine.

 

Does not contain hydrogen cyanide (HCN) or potassium cyanide (KCN).

 

No inhibitory effect from nicotine.

Does not contain HCN or KCN.

Oocyte pick-up rate

Cigarette smoke Cigarette smoke solutions of almost all brands, whether filtered or unfiltered, commercial, “harm reduction” or research cigarettes, reduced this rate by over 60%. The pick-up rate is inhibited by KCN in the levels found in cigarette smoke solutions.1

Contains nicotine.

 

No inhibitory effect from nicotine

Smooth muscle contraction

Smoke solutions from almost all traditional brands reduced muscle contraction by over 80%. Contraction of the ampulla inhibited during smoking, and not completely normalised after smoking.

Contains nicotine.

Nicotine decreases blood supply to the oviduct in rats, and in the Rhesus monkey, slowed oviductal contraction. This would be expected to interfere with transport of the fertilised embryo and fertility.

Cadmium. Present in tobacco of manufactured cigarettes tobacco (0.8 ppm dry weight, and in cigarette smoke: (56 ng per cigarette in NZ Holiday Extra mild,2 191ng per cigarette mean in 16 Canadian regular brands)3. Found to be higher in ovary of smokers (150ng/g) versus nonsmokers (115 ng/g).

Cadmium is present in trace amounts in oral tobacco (0.4 micrograms per gram (parts per million) dry weight).4 WHO sets a maximum of 52 micrograms per day in food.5

Cadmium not present in nicotine replacement products.

 

1 Talbot P. Riveles K. Smoking and reproduction: the oviduct as a target of cigarette smoke. Reproductive Biology and Endocrinology 2005; 3: 52 doi:10.1186/1477-7827-3-52. http://www.rbei.com/content/3/1/52

2 Fowles J. Chemical composition of tobacco and cigarette smoke in two brands of NZ cigarettes. ESR 2003. www.ndp.govt.nz

3.  Ministry of Health Planning. Government of British Columbia. What’s in cigarettes. Ingredients of mainstream smoke of cigarettes. http://www.healthservices.gov.bc.ca/cgi-bin/ttdr_ingredients_search.cgi?constituent=all  Accessed 25 October 2005. Health Canada intensive test mode.

4. Wahlberg I. TSNAs and metals in Swedish snus and in NZ cigarettes. Report to Health New Zealand Ltd 2003. http://www.endsmoking.org.nz/oralsnuff.htm

5. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004; 15: 252-263.

 

 Dr Murray Laugesen QSO chair; Prof Ross McCormick, Sir John Scott KBE, Trish Fraser MPH, Dr Marewa Glover, Trustees

Making it easier to quit smoking for good © 2009 End Smoking NZ